Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease

对轻症/中症SARS-CoV-2感染患者进行双抗治疗，以防止2019冠状病毒病发展为重症。